Risk and timing of cardiovascular death among patients with myelodysplastic syndromes

Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders associated with progression to leukemia and poor survival. Clonal hematopoiesis in people without an MDS diagnosis carries an increased risk of cardiovascular death. Many clonally restricted mutations are shared between pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Principais autores: Brunner, Andrew M., Blonquist, Traci M., Hobbs, Gabriela S., Amrein, Philip C., Neuberg, Donna S., Steensma, David P., Abel, Gregory A., Fathi, Amir T.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728287/
https://ncbi.nlm.nih.gov/pubmed/29296849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017010165
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados